160 related articles for article (PubMed ID: 35904852)
21. Sulfatase 2 Affects Polarization of M2 Macrophages through the IL-8/JAK2/STAT3 Pathway in Bladder Cancer.
Zhang W; Yang F; Zheng Z; Li C; Mao S; Wu Y; Wang R; Zhang J; Zhang Y; Wang H; Li W; Huang J; Yao X
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612128
[TBL] [Abstract][Full Text] [Related]
22. Current Status of Research on Small Extracellular Vesicles for the Diagnosis and Treatment of Urological Tumors.
Zhang M; Lu Y; Wang L; Mao Y; Hu X; Chen Z
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612097
[TBL] [Abstract][Full Text] [Related]
23. Predicting Tumor Perineural Invasion Status in High-Grade Prostate Cancer Based on a Clinical-Radiomics Model Incorporating T2-Weighted and Diffusion-Weighted Magnetic Resonance Images.
Zhang W; Zhang W; Li X; Cao X; Yang G; Zhang H
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612083
[TBL] [Abstract][Full Text] [Related]
24. The Effect of Oxidative Phosphorylation on Cancer Drug Resistance.
Zhao Z; Mei Y; Wang Z; He W
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612059
[TBL] [Abstract][Full Text] [Related]
25. The Ginsenoside Compound K Suppresses Stem-Cell-like Properties and Colorectal Cancer Metastasis by Targeting Hypoxia-Driven Nur77-Akt Feed-Forward Signaling.
Zhang M; Shi Z; Zhang S; Li X; To SKY; Peng Y; Liu J; Chen S; Hu H; Wong AST; Zeng JZ
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612021
[TBL] [Abstract][Full Text] [Related]
26. A risk-based postresection follow-up strategy for hepatocellular carcinoma patients.
Fu Y; Li X; Yang Z; Li S; Pan Y; Chen J; Wang J; Hu D; Zhou Z; Xu L; Chen M; Zhang Y
Cancer; 2023 Feb; 129(4):569-579. PubMed ID: 36541017
[TBL] [Abstract][Full Text] [Related]
27. Endoscopic balloon cryoablation plus transurethral resection for bladder cancer: A phase 2, multicenter, randomized, controlled trial.
Xu C; Jiang S; Zou L; Sheng L; Shi G; Xu B; Wang Z; Xu D; Xie X; Luo J; Guo J; Jiang H
Cancer; 2023 Feb; 129(3):415-425. PubMed ID: 36477612
[TBL] [Abstract][Full Text] [Related]
28. Exposure-Response Analyses of Tremelimumab Monotherapy or in Combination with Durvalumab in Patients with Unresectable Hepatocellular Carcinoma.
Song X; Kelley RK; Khan AA; Standifer N; Zhou D; Lim K; Krishna R; Liu L; Wang K; McCoon P; Negro A; He P; Gibbs M; Kurland JF; Abou-Alfa GK
Clin Cancer Res; 2023 Feb; 29(4):754-763. PubMed ID: 36477555
[TBL] [Abstract][Full Text] [Related]
29. First-in-Maintenance Therapy for Localized High-Grade Osteosarcoma: An Open-Label Phase I/II Trial of the Anti-PD-L1 Antibody ZKAB001.
Zhou Y; Yang Q; Dong Y; Ji T; Zhang B; Yang C; Zheng S; Tang L; Zhou C; Qian G; Huang Y; Yu W; Li H; Wang Y; He A; Shen Z; Bao Q; Hua Y; Bai H; Zhao J; Li X; Dai X; Zhang J; Hu H; Yao Y
Clin Cancer Res; 2023 Feb; 29(4):764-774. PubMed ID: 36469563
[TBL] [Abstract][Full Text] [Related]
30. Necroptosis-dependent Immunogenicity of Cisplatin: Implications for Enhancing the Radiation-induced Abscopal Effect.
Luo R; Onyshchenko K; Wang L; Gaedicke S; Grosu AL; Firat E; Niedermann G
Clin Cancer Res; 2023 Feb; 29(3):667-683. PubMed ID: 36449659
[TBL] [Abstract][Full Text] [Related]
31. The clinicopathological significance and relapse predictive role of tumor microenvironment of intrahepatic cholangiocarcinoma after radical surgery.
Zheng Y; Huang N; Kuang S; Zhang J; Zhao H; Wu J; Liu M; Wang L
Cancer; 2023 Feb; 129(3):393-404. PubMed ID: 36433731
[TBL] [Abstract][Full Text] [Related]
32. Treatment-related adverse events of antibody-drug conjugates in clinical trials: A systematic review and meta-analysis.
Zhu Y; Liu K; Wang K; Zhu H
Cancer; 2023 Jan; 129(2):283-295. PubMed ID: 36408673
[TBL] [Abstract][Full Text] [Related]
33. Deep learning radiomics of ultrasonography for comprehensively predicting tumor and axillary lymph node status after neoadjuvant chemotherapy in breast cancer patients: A multicenter study.
Gu J; Tong T; Xu D; Cheng F; Fang C; He C; Wang J; Wang B; Yang X; Wang K; Tian J; Jiang T
Cancer; 2023 Feb; 129(3):356-366. PubMed ID: 36401611
[TBL] [Abstract][Full Text] [Related]
34. Circulating Exosomal PD-L1 at Initial Diagnosis Predicts Outcome and Survival of Patients with Osteosarcoma.
Wang J; Guo W; Wang X; Tang X; Sun X; Ren T
Clin Cancer Res; 2023 Feb; 29(3):659-666. PubMed ID: 36374561
[TBL] [Abstract][Full Text] [Related]
35. Selectively Targeting STAT3 Using a Small Molecule Inhibitor is a Potential Therapeutic Strategy for Pancreatic Cancer.
Chen H; Zhou W; Bian A; Zhang Q; Miao Y; Yin X; Ye J; Xu S; Ti C; Sun Z; Zheng J; Chen Y; Liu M; Yi Z
Clin Cancer Res; 2023 Feb; 29(4):815-830. PubMed ID: 36374556
[TBL] [Abstract][Full Text] [Related]
36. An Enhancer Demethylator Phenotype Converged to Immune Dysfunction and Resistance to Immune Checkpoint Inhibitors in Clear-Cell Renal Cell Carcinomas.
Lu X; Vano Y; Helleux A; Su X; Lindner V; Davidson G; Mouawad R; Spano JP; Rouprêt M; Elaidi R; Compérat E; Verkarre V; Sun C; Chevreau C; Bennamoun M; Lang H; Tricard T; Cheng W; Xu L; Davidson I; Yan F; Fridman WH; Sautes-Fridman C; Oudard S; Malouf GG
Clin Cancer Res; 2023 Apr; 29(7):1279-1291. PubMed ID: 36374555
[TBL] [Abstract][Full Text] [Related]
37. Immune scoring model based on immune cell infiltration to predict prognosis in diffuse large B-cell lymphoma.
Yang J; Yu L; Man J; Chen H; Zhou L; Zhao L
Cancer; 2023 Jan; 129(2):235-244. PubMed ID: 36345617
[TBL] [Abstract][Full Text] [Related]
38. Gastric cancer incidence trends in China and Japan from 1990 to 2019: Disentangling age-period-cohort patterns.
Li Y; Ren N; Zhang B; Yang C; Li A; Li X; Lei Z; Fei L; Fan S; Zhang J
Cancer; 2023 Jan; 129(1):98-106. PubMed ID: 36284481
[TBL] [Abstract][Full Text] [Related]
39. Integrated clinical genotype-phenotype characteristics of early T-cell precursor acute lymphoblastic leukemia.
Ye MT; Wang Y; Zuo Z; Calin S; He H; Tang Z; Jabbour EJ; Borthakur G; Zhang Y; Yang Y; You MJ
Cancer; 2023 Jan; 129(1):49-59. PubMed ID: 36281717
[TBL] [Abstract][Full Text] [Related]
40. Development of Combination Strategies for Focal Adhesion Kinase Inhibition in Diffuse Gastric Cancer.
Peng K; Zhang F; Wang Y; Sahgal P; Li T; Zhou J; Liang X; Zhang Y; Sethi N; Liu T; Zhang H; Bass AJ
Clin Cancer Res; 2023 Jan; 29(1):197-208. PubMed ID: 36278961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
